Trifecta Capital Advisors, LLC Moderna, Inc. Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 14 shares of MRNA stock, worth $608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$608
Previous $1.66 Million
43.72%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRNA
# of Institutions
1,011Shares Held
243MCall Options Held
9.07MPut Options Held
13.1M-
Baillie Gifford & CO42.5MShares$1.85 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$1.72 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.11 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$653 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$314 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $17B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...